虚弱和透导管干预:一个叙述性审查
Hannah Kempton1,2, Rachael Hall1, Sara L Hungerford2,3,4
1Department of Cardiology, St Vincent's Hospital, Sydney, New South Wales, Australia.
概括
软弱性评估对于过导管门手术至关重要. 查脆弱性和综合老年病学评估可以优化患者,改善结果并降低死亡率.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 干预心脏病学 干预心脏病学
背景情况:
- 虚弱是经过过导管干预手术的患者不良结果和死亡率的重要预测因素.
- 目前的程序前脆弱性评估策略和干预措施需要进一步定义和评估.
研究的目的:
- 在跨导管干预队伍中审查脆弱性评估工具.
- 推一种程序前脆弱性评估的途径.
- 评估跨导管干预中脆弱性干预的证据.
主要方法:
- 系统审查在跨导管干预队列中的脆弱性评估工具和干预措施.
- 分析有关脆弱性干预措施有效性的现有证据.
主要成果:
- 建议使用虚弱查仪器来初步识别虚弱患者.
- 综合老年病症评估应跟随查,以帮助患者选择和优化.
- 有限的数据表明,以运动为基础的干预措施可以提高功能能力并减少脆弱性.
结论:
- 实施标准化脆弱性查和评估途径对于接受过导管门手术的患者至关重要.
- 需要进一步的研究来定义和验证旨在减少手术前脆弱性和改善患者结果的干预措施.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


